BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 145 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2015. The put-call ratio across all filers is 0.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $282,500,000 | -14.1% | 91,129 | 0.0% | 0.00% | – |
| Q3 2021 | $328,976,000 | +0.8% | 91,129 | 0.0% | 0.00% | – |
| Q2 2021 | $326,241,000 | -20.8% | 91,129 | -13.5% | 0.00% | – |
| Q1 2021 | $411,723,000 | -6.9% | 105,300 | 0.0% | 0.00% | – |
| Q4 2020 | $442,260,000 | +12.6% | 105,300 | 0.0% | 0.00% | – |
| Q3 2020 | $392,769,000 | -14.4% | 105,300 | 0.0% | 0.00% | – |
| Q2 2020 | $459,108,000 | -10.6% | 105,300 | -22.3% | 0.00% | – |
| Q1 2020 | $513,735,000 | -1.4% | 135,550 | +64.4% | 0.00% | – |
| Q4 2019 | $521,065,000 | +572498.9% | 82,447 | +191.3% | 0.00% | – |
| Q1 2016 | $91,000 | -40.1% | 28,300 | -10.7% | 0.00% | – |
| Q4 2015 | $152,000 | -13.6% | 31,700 | 0.0% | 0.00% | – |
| Q3 2015 | $176,000 | -30.2% | 31,700 | 0.0% | 0.00% | – |
| Q2 2015 | $252,000 | +30.6% | 31,700 | +72.3% | 0.00% | – |
| Q1 2015 | $193,000 | -7.7% | 18,400 | +5.7% | 0.00% | – |
| Q4 2014 | $209,000 | – | 17,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 2,000,000 | $7,820,000 | 6.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $37,262,000 | 0.78% |
| EMC Capital Management | 193,906 | $758,000 | 0.54% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,486,454 | $13,632,000 | 0.50% |
| ALGERT GLOBAL LLC | 344,210 | $1,346,000 | 0.43% |
| Hillsdale Investment Management Inc. | 877,000 | $3,430,000 | 0.29% |
| Stanley-Laman Group, Ltd. | 349,465 | $1,366,000 | 0.22% |
| SHEPHERD KAPLAN KROCHUK, LLC | 94,000 | $368,000 | 0.14% |
| GLOBEFLEX CAPITAL L P | 178,474 | $698,000 | 0.13% |
| Zebra Capital Management LLC | 23,622 | $92,000 | 0.10% |